Last edition
News about "EBITDA margins"
Gland Pharma Reports 16 Percent YoY Revenue Growth in Q1FY25
Gland Pharma has revealed its financial results for the first quarter of FY25, ending June 30, 2024.
EBITDA Margins | 07/08/2024 | By Aishwarya | 120
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members